BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2447904)

  • 1. Prediction of fetal alcohol syndrome by maternal alpha fetoprotein, human placental lactogen and pregnancy specific beta 1-glycoprotein.
    Halmesmäki E; Autti I; Granström ML; Heikinheimo M; Raivio KO; Ylikorkala O
    Alcohol Alcohol Suppl; 1987; 1():473-6. PubMed ID: 2447904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-fetoprotein, human placental lactogen, and pregnancy-specific beta 1-glycoprotein in pregnant women who drink: relation to fetal alcohol syndrome.
    Halmesmäki E; Autti I; Granström ML; Heikinheimo M; Raivio KO; Ylikorkala O
    Am J Obstet Gynecol; 1986 Sep; 155(3):598-602. PubMed ID: 2428250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy.
    Garoff L
    Obstet Gynecol; 1976 Dec; 48(6):659-66. PubMed ID: 63107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum levels of human alpha-fetoprotein, AFP, choriogonadotropin, hCG, placental lactogen, hPL, and pregnancy-specific beta 1-glycoprotein, SP1, are of no clinical significance in colorectal carcinoma.
    Szymendera JJ; Kaminska JA; Nowacki MP; Szawłowski AW; Gadek A
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1047-52. PubMed ID: 6173222
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of postterm pregnancies with maternal serum placental lactogen and alpha-fetoprotein concentrations.
    Josimovich JB; Soffronoff P; Starkovsky N; Mueller-Heubach E
    Obstet Gynecol; 1977 Oct; 50(4):445-9. PubMed ID: 71669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serial levels of HLP, SP1, SP3, and different proteins in pregnancy compared for their prognostic value (author's transl)].
    Viala JL; Bastide JM; Guibal J; Oudghiri T; Donati R
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(4):419-24. PubMed ID: 6161151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation.
    Gardner MO; Goldenberg RL; Cliver SP; Boots LR; Hoffman HJ
    Acta Obstet Gynecol Scand Suppl; 1997; 165():56-8. PubMed ID: 9219458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R; Marinov B; Milkov V; Milanov S
    Akush Ginekol (Sofiia); 1984; 23(4):315-20. PubMed ID: 6207743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Correlation between serum concentration of choriosomatotropin (HPL) and pregnancy-specific beta 1-glycoprotein in normal and pathological pregnancy].
    Skałba P; Dzieciuchowicz L; Rozmus M; Kokocińska D; Burak W
    Pol Tyg Lek; 1982 Apr; 37(8):217-20. PubMed ID: 6981106
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum SP1, HPL levels and urinary estrogen/creatinine ratio in the detection of low birth weight.
    Zhang WY; Teng H; Wang LY; Yan GL
    Chin Med J (Engl); 1993 Jun; 106(6):437-40. PubMed ID: 8222896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The laboratory in monitoring high-risk pregnancy].
    Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
    Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pre-eclampsia and placental hormones (author's transl)].
    Weber H; Heller S; Seulen P
    Geburtshilfe Frauenheilkd; 1980 Apr; 40(4):339-43. PubMed ID: 6966596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do pregnancy proteins have prospective significance? (SP-1, HPL and PP-5)].
    Tatra G; Lüben G; Nasr F
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):363-6. PubMed ID: 3874806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection and measurement of oncodevelopmental proteins in gynecological malignant disease.
    Cerni C; Tatra G
    Arch Gynecol; 1982; 231(2):159-65. PubMed ID: 6176191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental proteins as tumor markers.
    Braunstein GD
    Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormally elevated pregnancy specific beta 1 glycoprotein (SP1 beta) with very low placental lactogen (hPL) concentrations in a pregnancy with satisfactory outcome.
    Pledger DR; McEwan HP
    Acta Obstet Gynecol Scand; 1984; 63(7):663-5. PubMed ID: 6393689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay of serum SP 1 and HPL in normal and abnormal pregnancies.
    Pluta M; Hardt W; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
    Arch Gynecol; 1979; 227(4):327-36. PubMed ID: 316310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating placental proteins in pregnancies complicated by RH isoimmunization.
    Lee JN; Huang SC; Ouyang PC; Chard T
    Obstet Gynecol; 1984 Jul; 64(1):131-2. PubMed ID: 6429588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.